Ionis Pharmaceuticals IONS Effective Income Tax Rate Reconciliation, Tax Credit, Amount
Effective Income Tax Rate Reconciliation, Tax Credit, Amount at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCredits.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, amount?
- Ionis Pharmaceuticals (IONS) reported effective income tax rate reconciliation, tax credit, amount of $13.37M in Q4 2024.
- How has Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, amount changed year-over-year?
- Ionis Pharmaceuticals's effective income tax rate reconciliation, tax credit, amount decreased by 20.3% year-over-year, from $16.78M to $13.37M.
- What does effective income tax rate reconciliation, tax credit, amount mean?
- The total monetary value of tax credits used to lower the company's tax bill.
- How do you interpret effective income tax rate reconciliation, tax credit, amount?
- An increase indicates higher utilization of government tax incentives, often due to increased R&D activity.
- How does effective income tax rate reconciliation, tax credit, amount compare across companies?
- Common in biotech and pharmaceutical firms with heavy R&D spending.